勘误：阿格列汀对二甲双胍单药治疗控制不佳的肥胖2型糖尿病患者肺功能的影响：勘误。
Erratum: The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy: Erratum.
出版信息
Medicine (Baltimore). 2016 Oct 21;95(42):e18ea. doi: 10.1097/01.md.0000505546.85718.ea. eCollection 2016 Oct.
Abstract
[This corrects the article DOI: 10.1097/MD.0000000000004541.].
摘要
[本文更正了文章的数字对象标识符：10.1097/MD.0000000000004541。]
相似文献
1
Erratum: The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy: Erratum.
Medicine (Baltimore). 2016 Oct 21;95(42):e18ea. doi: 10.1097/01.md.0000505546.85718.ea. eCollection 2016 Oct.
2
The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy.
Medicine (Baltimore). 2016 Aug;95(33):e4541. doi: 10.1097/MD.0000000000004541.
3
Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes.
J Clin Endocrinol Metab. 2012 May;97(5):1615-22. doi: 10.1210/jc.2011-2243. Epub 2012 Mar 14.
4
Erratum: Medicine, Volume 95, Issue 23: Erratum.
Medicine (Baltimore). 2016 Jul 18;95(28):e0916. doi: 10.1097/01.md.0000489580.04709.16. eCollection 2016 Jul.
5
Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.
Diabetes Ther. 2017 Apr;8(2):251-273. doi: 10.1007/s13300-017-0245-8. Epub 2017 Mar 8.
6
Alogliptin: a review of its use in patients with type 2 diabetes mellitus.
Drugs. 2015 May;75(7):777-96. doi: 10.1007/s40265-015-0385-y.
7
The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus.
Diabetes Ther. 2016 Dec;7(4):825-845. doi: 10.1007/s13300-016-0206-7. Epub 2016 Oct 27.
8
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: a randomized, double-blind, placebo-controlled study.
Diabetes Care. 2008 Dec;31(12):2315-7. doi: 10.2337/dc08-1035. Epub 2008 Sep 22.
9
Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
Curr Med Res Opin. 2006 Apr;22(4):751-9. doi: 10.1185/030079906X104786.
10
Alogliptin benzoate for the treatment of type 2 diabetes.
Expert Opin Pharmacother. 2012 Mar;13(4):553-63. doi: 10.1517/14656566.2012.656088. Epub 2012 Feb 1.
本文引用的文献
1
The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy.
Medicine (Baltimore). 2016 Aug;95(33):e4541. doi: 10.1097/MD.0000000000004541.
Zotero 插件